(16:23 GMT) Oruka Therapeutics Price Target Raised to $130.00/Share From $100.00 by UBS
Dow Jones Newswires
Oruka Therapeutics Is Maintained at Buy by UBS
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:ORKA
- Language
- English
(16:23 GMT) Oruka Therapeutics Price Target Raised to $130.00/Share From $100.00 by UBS